(MENAFNEditorial) MHRA and US FDA to discuss innovation in Controlled Release
SMi''s 13th annual Controlled Release conference will feature case studies from regulatory bodies and an array of global pharmaceutical companies. LONDON ENGLAND UNITED KINGDOM March 30 2016 /EINPresswire.com/ -- Could you benefit from hearing exclusive presentations and briefings from 11 global pharma companies covering in detail their own experiences in driving Controlled Release innovation?
If the answer is yes book now to learn from your industry peers and gain valuable insight into their current strategies and future outlook to improve CR formulation and delivery for next generation drugs.
In addition to the array of pharma case studies SMi is proud to announce that the MHRA and US FDA will be sharing their own unique perspectives at the 13th annual Controlled Release conference taking place on 18th - 19th April 2016 in London highlighting scientific and regulatory challenges along with how these have been overcome:
MHRA''s Pharmaceutical Assessor Marion Westwood will share an opening address on Day One titled ''Supporting innovation in controlled release and combination products''. Her presentation will cover the following key points:
Discuss the latest innovations surrounding controlled release
Gain key regulatory updates from leading competent authorities talking specifically on grey areas such as the regulatory environment surrounding combination products
Case study on work with OxSonics
US FDA''s Pharmacologist Mohammad Absar will be delivering a presentation at 13:50 on Day One titled ''Regulatory perspective on innovative systems for controlled release''. Key points covered include:
An overview of current innovative controlled release systems in the US market
Scientific and regulatory challenges in developing generic controlled release systems
FDA/OGD''s ongoing research programme
Additionally the two-day programme also promises to bring you the cutting-edge developments highlighting:
New platforms in Controlled Release delivery
CriticalMix platform technology: A novel platform technology for sustained delivery of small and large APIs by Critical Pharmaceuticals
Diurnal on optimising drug delivery systems to mimic the human circadian rhythm
Innovations in Controlled Release
MedImmune talks about controlling peptide stability to unlock therapeutic potential
AstraZeneca presents nanomedicine design for controlled release
The importance of QbD
GSK examines how Quality by Design (QbD) can aid formulation and controlled release delivery
Novo Nordisk demonstrates application of QbD during spray drying scale-up
Product Design
Parenteral controlled release: Revival for increased adherence case study by Merck
Lundbeck showcases how to formulate poorly soluble drugs
To view the full speaker line-up and conference programme visit http://www.controlledrelease.co.uk/einpresswire
Plus don''t forget to extend your stay to join the 2 post-conference interactive workshops taking place on Wednesday 20th April 2016:
Workshop A: QbD/PAT Driven Controlled Release Design and Development
Hosted by by Daniela Stranges Senior Scientist Quality by Design Integration GlaxoSmithKline and Jerome Mantanus Senior Scientist QbD/PAT Drug Product Formulation UCB Pharma
Enhance understanding on the adoption of core principles of Quality by Design (QbD) for controlled release development and manufacturing. This workshop defines how QbD tools (DoEs PAT) can be applied to support formulation and process development.
Workshop B: Exploring Controlled Release Drug Delivery Methods
Hosted by Rene Holm Senior Director Lundbeck; Clive Wilson Professor of Pharmaceutics University of Strathclyde; Ijeoma Uchegbu Scientific Secretary CRS Chair in Pharmaceutical Nanoscience University of London and CEO Nanometrics
This workshop will explore drug delivery technologies that can be utilised in controlled release drug delivery and will consider some of the newer concepts in the drug delivery world including nanotechnology.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.